Guangdong Jiaying Pharmaceutical Co Ltd
002198
Company Profile
Business description
Guangdong Jiaying Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is mainly engaged in the research and development, production, and sales of pharmaceuticals. The company's main products cover throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal. Its product portfolio consists of Shuangliao Houfeng San, Chongganling Tablets, Jiegu Qili Tablets (Capsules), Shufeng Huoluo Tablets, Tiaojing Huoxue Tablets, etc.
Contact
Dongsheng Industrial Park
Zone B
Guangdong Province
Meizhou514021
CHNT: +86 7532321916
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
594
Stocks News & Analysis
stocks
Wildly overvalued ASX stock is skating on thin ice
This company dominates its industry and could be flirting with regulatory intervention.
stocks
Uber flexes its network effect and delivers strong result
Uber’s business is humming along but autonomous vehicles add uncertainty to the longer term outlook.
stocks
Ask the analyst: Are Qantas shares a value trap?
Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,095.80 | 6.20 | -0.07% |
| CAC 40 | 7,709.32 | 74.29 | 0.97% |
| DAX 40 | 24,192.50 | 268.14 | 1.12% |
| Dow JONES (US) | 43,968.64 | 224.48 | -0.51% |
| FTSE 100 | 9,100.77 | 63.54 | -0.69% |
| HKSE | 25,081.63 | 171.00 | 0.69% |
| NASDAQ | 21,242.70 | 73.27 | 0.35% |
| Nikkei 225 | 41,790.37 | 731.22 | 1.78% |
| NZX 50 Index | 12,903.41 | 16.31 | 0.13% |
| S&P 500 | 6,340.00 | 5.06 | -0.08% |
| S&P/ASX 200 | 8,827.80 | 3.60 | -0.04% |
| SSE Composite Index | 3,639.67 | 5.67 | 0.16% |